Apr 07, 2021 / 05:00PM GMT
Will Gramig -
Good afternoon. This is Will Gramig with Stern Investor Relations, and welcome to Cara Therapeutics' 2021 R&D Day. As a reminder, we will be making some forward-looking statements today. We would encourage you to review Cara's most recent SEC filings for a more complete description of our risk factors.
Cara management is delighted to be joined on the webinar today by 2 highly accomplished key opinion leaders, Dr. Brian Kim and Dr. Mark Lebwohl. Dr. Brian Kim is an Associate Professor of Medicine and the Co-Director of the Center for the Study of Itch and Sensory Disorders at Washington University School of Medicine in St. Louis. Dr. Mark Lebwohl is a professor of Dermatology and the Dean for Clinical Therapeutics at the Icahn School of Medicine at Mount Sinai in New York. Participating from Cara today will be Dr. Derek Chalmers, Cara's President and Chief Executive Officer; Dr. Joana Goncalves, Cara's Chief Medical Officer; Mr. Eric Vandal, Cara's Senior Vice President of Commercial Operations; and Mr. Tom Reilly, Cara's Chief Financial Officer.
Today's event is expected to run
Cara Therapeutics Inc R&D Day Transcript
Mar 02, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers